These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS). Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Charlton-Menys V, DeMicco DA, Fuller JH, CARDS Investigators. Am J Kidney Dis; 2009 Nov; 54(5):810-9. PubMed ID: 19540640 [Abstract] [Full Text] [Related]
28. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis. Goldfarb-Rumyantzev AS, Habib AN, Baird BC, Barenbaum LL, Cheung AK. Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292 [Abstract] [Full Text] [Related]
29. Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients. Espe KM, Raila J, Henze A, Blouin K, Schneider A, Schmiedeke D, Krane V, Pilz S, Schweigert FJ, Hocher B, Wanner C, Drechsler C, German Diabetes and Dialysis Study Investigators. Clin J Am Soc Nephrol; 2013 Mar; 8(3):452-8. PubMed ID: 23335039 [Abstract] [Full Text] [Related]
31. Inverse Association Between Serum Non-High-Density Lipoprotein Cholesterol Levels and Mortality in Patients Undergoing Incident Hemodialysis. Chang TI, Streja E, Ko GJ, Naderi N, Rhee CM, Kovesdy CP, Kashyap ML, Vaziri ND, Kalantar-Zadeh K, Moradi H. J Am Heart Assoc; 2018 Jun 09; 7(12):. PubMed ID: 29886420 [Abstract] [Full Text] [Related]
32. Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis. Rhee CM, Kovesdy CP, You AS, Sim JJ, Soohoo M, Streja E, Molnar MZ, Amin AN, Abbott K, Nguyen DV, Kalantar-Zadeh K. Am J Kidney Dis; 2018 Nov 09; 72(5):701-710. PubMed ID: 30037725 [Abstract] [Full Text] [Related]
34. Lipoprotein-associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysis. Winkler K, Hoffmann MM, Krane V, Drechsler C, Wanner C, German Diabetes and Dialysis Study Investigators. Eur J Clin Invest; 2012 Jul 09; 42(7):693-701. PubMed ID: 22211481 [Abstract] [Full Text] [Related]
37. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study. Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M, LCP-AtorFen Investigators. Clin Ther; 2009 Dec 09; 31(12):2824-38. PubMed ID: 20110022 [Abstract] [Full Text] [Related]
38. Association of diabetes with cardiovascular calcification and all-cause mortality in end-stage renal disease in the early stages of hemodialysis: a retrospective cohort study. Li Q, Li P, Xu Z, Lu Z, Yang C, Ning J. Cardiovasc Diabetol; 2024 Jul 18; 23(1):259. PubMed ID: 39026232 [Abstract] [Full Text] [Related]
39. Atorvastatin in patients with type 2 diabetes mellitus undergoing dialysis. Robinson JG. N Engl J Med; 2005 Oct 27; 353(17):1858-60; author reply 1858-60. PubMed ID: 16252415 [No Abstract] [Full Text] [Related]
40. Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Results of a prospective study. The German Study Group Diabetes and Uremia. Tschöpe W, Koch M, Thomas B, Ritz E. Nephron; 1993 Oct 27; 64(3):354-8. PubMed ID: 8341379 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]